Rapid liquid chromatography–tandem mass spectrometry method for quantification of ziprasidone in human plasma
- 15 September 2005
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 20 (4) , 365-368
Abstract
A liquid chromatography–tandem mass spectrometry (LC‐MS/MS) method for the determination of ziprasidone (ZIP) in human plasma was developed. ZIP and N‐methyl ziprasidone as internal standard (IS) were extracted from alkalinized plasma using tert‐ butyl methyl ether. Separation was performed isocratically on a C8 column with 90% acetonitrile containing 2 mmol/L ammonium acetate as a mobile phase with a total run time of 2.5 min. MS/MS transitions of m/z 413 → 194 and m/z 427 → 177 of the analyte and internal standard were used for quantification. Confirmatory ions of m/z 413 → 177 and m/z 427 → 180 were collected as well. The calibration curve based on peak‐area ratio was linear up to at least 200 ng/mL with a detection limit of 0.1 ng/mL. The method showed satisfactory reproducibility with a coefficient of variation of less than 5%. The method was successfully applied to the analysis of ZIP in spiked human plasma. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 10 references indexed in Scilit:
- Automated Determination of Ziprasidone by HPLC With Column Switching and Spectrophotometric DetectionTherapeutic Drug Monitoring, 2005
- Stability indicating reversed‐phase high‐performance liquid chromatographic and thin layer densitometric methods for the determination of ziprasidone in bulk powder and in pharmaceutical formulationsBiomedical Chromatography, 2003
- Determination of plasma ziprasidone using liquid chromatography with fluorescence detectionJournal of Chromatography B, 2003
- Ziprasidone: The Fifth Atypical AntipsychoticAnnals of Pharmacotherapy, 2002
- Spotlight on Ziprasidone in Schizophrenia and Schizoaffective Disorder*CNS Drugs, 2002
- ZiprasidoneDrugs, 2002
- Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactionsBritish Journal of Clinical Pharmacology, 2000
- Automated sample preparation using membrane microtiter extraction for bioanalytical mass spectrometryRapid Communications in Mass Spectrometry, 1997
- Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.The Journal of Pharmacology and Experimental Therapeutics, 1995
- Development and validation of a high-sensitivity assay for an antipsychotic agent, CP-88,059, with solid-phase extraction and narrow-bore high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1995